IL1B and dermatitis: In addition, topical application of WY-14643 (pirinixic acid), a specific PPARα ligand, reduces the expression of the pro-inflammatory cytokines IL-1β and IL-6 and attenuates skin inflammation in atopic dermatitis (Staumont-Sallé et al., 2008).